Evidence map›Paper›PMID 31333784›Full record

ArticleJournal of Cancer2019

A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4.

Jieshu You, Fei Gao, Hailin Tang, Fu Peng, Lei Jia, Kun Huang, Kinlong Chow, Jiaqi Zhao, Huanlan Liu, Yi Lin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. International journal of molecular sciences · 2023
    Article
  4. Article
  5. Nephrotoxicity in cancer treatment: An update.Advances in cancer research · 2022
    Article
  6. Acoustofluidic Droplet Sorter Based on Single Phase Focused Transducers.Small (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jieshu YouBasic Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Fei GaoSchool of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
Hailin TangGalactophore Department, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong Province, China.
Fu PengSchool of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
Lei JiaSchool of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
Kun HuangSchool of Biological Science, The University of Hong Kong, Hong Kong, China.
Kinlong ChowSchool of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
Jiaqi ZhaoSchool of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
Huanlan LiuBasic Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Yi LinGalactophore Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong Province, China.
Jianping ChenSchool of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
University of Hong Kong · HKGuangdong Provincial Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy is the most common and powerful cancer treatment. Although the nasty side effects seriously influence the clinical practice, no better ways can displace it. Therefore, searching for safe and effective strategies designed to ameliorate chemotherapy-induced toxicity has become an urgent issue in cancer research area. In clinical, a medicinal and edible formula YH0618 showed the effects of reducing the DOX-induced toxicity, especially improving alopecia, nail discoloration, skin hyperpigmentation and fatigue. This study was to investigate the role and mechanism of YH0618 in ameliorating DOX-induced toxicity by

Indexed as

ApoptosisBcl-2/BaxDOX-induced toxicityFOXO4Medicine and food homologyYH0618

Identifiers

PMID31333784
PMCPMC6636307
OpenAlexW2950066806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.